Search Results for: lawsuits

2 State AG’s sue ‘Stem Cell Centers’ clinics including for alleged fraud

Travis-Autor

Some readers suggested earlier this year that I look into a clinic firm called ‘Stem Cell Centers’ with its owner Travis Autor. I didn’t have time to do much since I’ve been very busy in the lab before the state Attorney Generals of Iowa and Nebraska sued them based on a number of allegations including […]

2 State AG’s sue ‘Stem Cell Centers’ clinics including for alleged fraud Read More »

Liveyon is back (again) with unproven exosome product

Liveyon

Remember our old friends Liveyon? Their leader John Kosolcharoen? Liveyon’s continuing metamorphosis This biologics supply firm has gone through several stages of corporate metamorphosis as a supplier of biologics including at first a purported living umbilical cord stem cell product. That stem cell thrust ultimately landed a dozen or more people in the hospital as

Liveyon is back (again) with unproven exosome product Read More »

20/20 vision? The Niche’s 20 stem cell & regenerative medicine predictions for 2020

The-Niche-stem-cell-predictions-2020

Every year in December and early January I do a post predicting some key events for the stem cell and regenerative medicine field for the upcoming year and today’s post contains my predictions for 2020. You can see my past 2019 predictions along with my grades for them here. I gave myself a B+ for

20/20 vision? The Niche’s 20 stem cell & regenerative medicine predictions for 2020 Read More »

B+ on my report card on my 20 stem cell predictions for 2019

stem-cell-crystal-ball-predictions-1

Last year around this time I took my annual plunge to make 20 predictions for the coming year for the stem cell and regenerative medicine field. I even made a crystal ball graphic to highlight the complexity of the stem cell ecosystem into which these predictions were embedded (see image) for 2019. How’d I do?

B+ on my report card on my 20 stem cell predictions for 2019 Read More »

‘I’d need a drink’: WaPo deep dive on clinic firm Lung Health Institute

H-CYTE-Ann-Sells-Miller

Washington Post reporters William Wan and Laurie McGinley have a new piece on the unproven regenerative clinic firm the Lung Health Institute. This article has a number of surprises and new insights. Previously the Lung Health Institute was called just the Lung Institute. It was recently acquired by the publicly-traded company H-CYTE, stock symbol HCYT. In the

‘I’d need a drink’: WaPo deep dive on clinic firm Lung Health Institute Read More »

Bad Batch podcast’s dark picture of perinatal stem cell industry

John Kosolcharoen, Liveyon

I finished listening to the first 6 episodes of the Bad Batch podcast last week. The series is by medical journalist Laura Beil. I think there will be a 7th episode that’s a Q&A. I highly recommend listening to the series even if parts are wrenching at times like how much patients and families have

Bad Batch podcast’s dark picture of perinatal stem cell industry Read More »

Richard Garr Q&A on his new Right-To-Try firm Beacon of Hope

NSRichard08-headshot

A new right-to-try company called Beacon of Hope is stirring some intense discussion. State and federal right-to-try laws could potentially change the fabric of how many investigational studies are conducted. That may happen through firms like Beacon of Hope. However, we don’t know much about the firm. I’m hoping to help change that. Today’s post

Richard Garr Q&A on his new Right-To-Try firm Beacon of Hope Read More »

Kristin Comella resigns from embattled clinic firm US Stem Cell

Kristin-Comella

US Stem Cell, Inc. reports in a new SEC filing that its key leader Kristin Comella has resigned as of September 1. I never thought I’d see the day when Kristin Comella and US Stem Cell, Inc. parted ways. To me Comella seemed like the driving force behind the company, which is now subject to

Kristin Comella resigns from embattled clinic firm US Stem Cell Read More »